Gender differences in corydaline pharmacokinetics in rats

References

• Benet LZ, Hoener BA. (2002). Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 71:115–21
   PubMed Web of Science ®Google Scholar
• Boudinot FD, Jusko WJ. (1984). Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 73:774–80
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54
   PubMed Web of Science ®Google Scholar
• Chiou WL. (1978). Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level–time curve. J Pharmacokinet Biopharm 6:539–46
   PubMedGoogle Scholar
• Choi S, Choi JJ, Jun JY, et al. (2009). Induction of pacemaker currents by DA-9701, a prokinetic agent, in interstitial cells of Cajal from murine small intestine. Mol Cells 27:307–12
   PubMedGoogle Scholar
• Gibaldi M, Perrier D, eds. (1982). Pharmacokinetics, 2nd ed. New York: Marcel-Dekker, Inc
   Google Scholar
• Ji HY, Im SR, Lee HR, Lee HS. (2011a). In vitro metabolism of corydaline and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes. 17th North American Regional ISSX (International Society for the Study of Xenobiotics) Meeting. Atlanta, GA
   Google Scholar
• Ji HY, Liu KH, Lee H, et al. (2011b). Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules 16:6591–602
   PubMed Web of Science ®Google Scholar
• Ji HY, Lee H, Kim JH, et al. (2012). In vitro metabolism of corydaline in human liver microsomes and hepatocytes using liquid chromatography-ion trap mass spectrometry. J Sep Sci 35:1102–9
   PubMedGoogle Scholar
• Jung JW, Kim JM, Jeong JS, et al. (2014). Pharmacokinetics of chlorogenic acid and corydaline in DA-9701, a new botanical gastroprokinetic agent, in rats. Xenobiotica 44:635–43
   PubMed Web of Science ®Google Scholar
• Jung YS, Kim MY, Lee HS, et al. (2013). Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats. Neurogastroenterol Motil 25:254–9
   PubMed Web of Science ®Google Scholar
• Kim ER, Min BH, Lee SO, et al. (2012). Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs. J Gastroenterol Hepatol 27:766–72
   PubMedGoogle Scholar
• Kim JM, Yoon JN, Jung JW, et al. (2013). Pharmacokinetics of hederacoside C, an active ingredient in AG NPP709, in rats. Xenobiotica 43:985–92
   PubMed Web of Science ®Google Scholar
• Kubo M, Matsuda H, Tokuoka K, et al. (1994). Anti-inflammatory activities of methanolic extract and alkaloidal components from Corydalis tuber. Biol Pharm Bull 17:262–5
   PubMed Web of Science ®Google Scholar
• Kwon YS, Son M. (2013). DA-9701: a new multi-acting drug for the treatment of functional dyspepsia. Biomol Ther (Seoul) 21:181–9
   PubMedGoogle Scholar
• Lee JH, Lee MG. (2008). Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin. Pharm Res 25:1915–24
   PubMed Web of Science ®Google Scholar
• Lee KJ, Suh Y. (2012). Molecular application to identify Corydalis tubers. Planta Med 78:OP15
   Google Scholar
• Lee MG, Chiou WL. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623–40
   PubMedGoogle Scholar
• Lee TH, Choi JJ, Kim DH, et al. (2008). Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis tuber. Phytomedicine 15:836–43
   PubMedGoogle Scholar
• Lee TH, Son M, Kim SY. (2010). Effects of corydaline from Corydalis tuber on gastric motor function in an animal model. Biol Pharm Bull 33:958–62
   PubMed Web of Science ®Google Scholar
• Lewis DFV. (1996). Cytochromes P450 structure, function and mechanism. London: Taylor & Francis
   Google Scholar
• Liu YZ, Yang XB, Yang XW, et al. (2013). Biotransformation by human intestinal flora and absorption-transportation characteristic in a model of Caco-2 cell monolayer of d-corydaline and tetrahydropalmatine. Zhongguo Zhong Yao Za Zhi 38:112–18
   PubMedGoogle Scholar
• Matsuda H, Tokuoka K, Wu J, et al. (1995). Inhibitory effects of methanolic extract from corydalis tuber against types I–IV allergic models. Biol Pharm Bull 18:963–7
   PubMed Web of Science ®Google Scholar
• Øie S, Guentert TW. (1982). Comparison of equilibrium time in dialysis experiments using spiked plasma or spiked buffer. J Pharm Sci 71:127–8
   PubMed Web of Science ®Google Scholar
• Parkinson A, Mudra DR, Johnson C, et al. (2004). The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199:193–209
   PubMed Web of Science ®Google Scholar
• Soucek P, Gut I. (1992). Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 22:83–103
   PubMed Web of Science ®Google Scholar
• Wilkinson GR, Shand DG. (1975). Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–90
   PubMed Web of Science ®Google Scholar
• Wojcikowski J, Haduch A, Daniel WA. (2012). Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver. Pharmacol Rep 64:1411–8
   PubMed Web of Science ®Google Scholar
• Yuan CS, Mehendale SR, Wang CZ, et al. (2004). Effects of Corydalis yanhusuo and Angelicae dahuricae on cold pressor-induced pain in humans: a controlled trial. J Clin Pharmacol 44:1323–7
   PubMed Web of Science ®Google Scholar